NT5DC3 and cancer: NT5DC1/2 DNA methylation levels in tumor tissue were lower than those in normal tissue, while the DNA methylation levels of NT5DC3 were significantly increased in tumor tissue, suggesting that DNA methylation-targeting drugs may have applications in cancer treatment 36 as they implicate epigenetic regulation in the biological process of PAAD induced by the NT5DC family.